What is the product positioning strategy for two novel early stage IO candidates for global pharma company?

Client Problems

• Which indications should the IO candidates be prioritized for?

  
   

• How does the product positioning affect the overall IO portfolio for the company?

  
   

• Go/no-go decision on mono / combotherapy

What We Did

• Workshop with client for indication prioritization

  
   

• TPP generation for each candidate across indications

  
   

• Determined the impact of the candidate on the overall portfolio

  
   

• Prioritized the indication selections

Our Results And Insight

• Estimated revenue potential
   

• Indication prioritization
   

• Portfolio management